TNXP (STOCKS)
Tonix Pharmaceuticals Holding Corp.
$11.530000
+0.180000 (+1.59%)
Prev close: $11.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Seth Lederman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $183.64M
- Employees
- 81
- P/E (TTM)
- -0.79
- P/B (TTM)
- 0.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-2.93 | $-2.48 | -0.4480 | -18.05% |
|
Dec 2025 (Q4)
|
$-3.98 | $-3.25 | -0.7262 | -22.32% |
|
Sep 2025 (Q3)
|
$-3.59 | $-3.66 | +0.0667 | +1.82% |
|
Jun 2025 (Q2)
|
$-3.86 | $-3.28 | -0.5807 | -17.71% |
Financial Statements
| Revenues | $17.56M |
| Benefits Costs and Expenses | $168.74M |
| Cost Of Revenue | $7.28M |
| Costs And Expenses | $168.74M |
| Gross Profit | $10.28M |
| Operating Expenses | $161.47M |
| Selling, General, and Administrative Expenses | $106.20M |
| Depreciation and Amortization | $2.00M |
| Research and Development | $55.26M |
| Operating Income/Loss | -$151.19M |
| Income/Loss From Continuing Operations After Tax | -$147.39M |
| Income/Loss From Continuing Operations Before Tax | -$151.16M |
| Net Income/Loss | -$147.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$147.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$147.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$14.53 |
| Diluted Earnings Per Share | -$14.53 |
| Basic Average Shares | 31,065,071 |
| Diluted Average Shares | 31,065,071 |
| Assets | $257.91M |
| Current Assets | $207.17M |
| Noncurrent Assets | $50.74M |
| Fixed Assets | $44.89M |
| Intangible Assets | $120.00K |
| Other Non-current Assets | $5.73M |
| Liabilities | $30.78M |
| Current Liabilities | $29.65M |
| Accounts Payable | $9.65M |
| Other Current Liabilities | $20.00M |
| Noncurrent Liabilities | $1.13M |
| Equity | $227.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $227.14M |
| Liabilities And Equity | $257.91M |
| Net Cash Flow From Operating Activities | -$125.58M |
| Net Cash Flow From Operating Activities, Continuing | -$125.58M |
| Net Cash Flow From Investing Activities | -$6.21M |
| Net Cash Flow From Investing Activities, Continuing | -$6.21M |
| Net Cash Flow From Financing Activities | $185.20M |
| Net Cash Flow From Financing Activities, Continuing | $185.20M |
| Exchange Gains/Losses | -$16.00K |
| Net Cash Flow | $53.39M |
| Net Cash Flow, Continuing | $53.41M |
| Comprehensive Income/Loss | -$147.40M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$147.40M |
| Other Comprehensive Income/Loss | -$119.13M |